Study aiming at reducing the risk of diabetes using omega-3 fish oil
Helping advanced scientific knowledge on disease while benefiting from a medical examination, does that appeal to you? IRCM clinic is inviting adult Canadians to benefit from a clinical study aiming at preventing type 2 diabetes. You will be part of a study examining the effects of 6-month supplementation with omega-3 oil, which is naturally found in fish and sea products, in treating newly discovered risk factors for type 2 diabetes in humans. If qualified for the study, participants will benefit from a comprehensive medical examination consisting of specialized tests that are only available in clinical research setting. They will obtain detailed analyses of their body composition (bone density and percent of body fat and muscle) and information related to their health including the risk of developing type 2 diabetes. All tests and supplementation are covered by the research project. Note that participants will receive a financial compensation up to $500 for their time and expenses related to this study.
The study is under the supervision of Dr. May Faraj, professor of nutrition at the Université de Montréal (UdeM), and director of the Research Unit on nutrition, lipoproteins and cardiometabolic diseases at IRCM.
Inclusion criteria
- Men; aged 45 to 74 years
- Women; aged 45 to 74 years with menopause and without hormone therapy replacement
- Having excess body weight
- Being non-smoker
- Without diagnosis of type 2 diabetes or heart disease
- Not using any medication for high blood pressure or cholesterol
- Being available for the duration of the study (10 visits over the span of 33 weeks, including 4 full-day visits at IRCM)
This study is supported by Canadian Institutes of Health Research (CIHR) and is registered online at https://clinicaltrials.gov/ct2/show/NCT04485871
Information
- Jutine Fricher, MSc
- T2Dresearch@ircm.qc.ca
- (514) 987-5500 x3260
